• Sonuç bulunamadı

2015 Subject Index

N/A
N/A
Protected

Academic year: 2021

Share "2015 Subject Index"

Copied!
1
0
0

Yükleniyor.... (view fulltext now)

Tam metin

(1)

Acute exacerbation/Akut alevlenme ... 48

Acute failure-on-chronic liver/Kronik karaciğerde akut yetmezlik... 48

Acute hepatitis B/Akut hepatit B ... 98

Acute liver failure/Akut karaciğer yetmezliği ... 98

Acute pancreatitis/Akut pankreatit ... 35

Age-specific anti-HCV/Yaş gruplarında anti-HCV ... 40

Animal models/Hayvan modelleri ... 65

Antenatal/Doğum öncesi takip ... 31

Anti HAV IgG/Anti HAV IgG ... 24

Anti HAV IgM/Anti HAV IgM ... 24

Anti-HCV/Anti-HCV ...28, 40, 76 Anti-HIV/Anti-HIV ...28, 76 Biology/Biyoloji ... 1

Biopsy/Biyopsi ... 53

Blood donors/Kan bağışçıları ... 28

Cholestasis/Kolestaz ... 98

Chronic hepatitis B/Kronik hepatit B ... 17, 35, 48, 89 Chronic hepatitis C/Kronik hepatit C ...59, 102 Chronic viral hepatitis/Kronik viral hepatit ... 9

Cirrhosis/Siroz ...89, 102 Co-infection/Koenfeksiyon ... 80

Cost savings/Maliyet tasarrufu ... 76

DNA/DNA ... 53

Drug resistance/İlaç direnci ... 85

Economic evaluation/Ekonomik değerlendirme ... 76

Fibrosis/Fibroz ...9, 80 Genotype 1b/Genotip 1b ... 13

Genotype 4/Genotip 4 ... 13

HBsAg/HBsAg ...28,76 HBV DNA/HBV DNA ...106

HBV reactivation/HBV reaktivasyonu ...106

HBV/HBV ...1, 31 HCV seroprevalence/HCV seroprevalans ... 40

HCV/HCV ...13, 31 Hepatitis A virüs/Hepatit A virüs ...21, 72 Hepatitis A/Hepatit A ... 94

Hepatitis B virus/Hepatit B virüs ...1, 53, 80 Hepatitis B/Hepatit B ...44,85, 94 Hepatitis C virus infection/Hepatitis C virüs enfeksiyonu .. 40

Hepatitis C/Hepatit C ... 38, 62, 65, 94 Hepatitis D virus/Hepatit D virüs ... 80

Hepatitis delta/Delta hepatit ...80, 89 IgG/IgG ...21, 72 IgM/IgM ...21, 72 Immunity/Bağışıklık ... 44

Immunosuppression/İmmünsupresyon ... 56

Inactive carriers/İnaktif taşıyıcılık ... 89

Interferon/İnterferon ...62, 80 Interferons/İnterferonlar ...102

Lamivudine/Lamivudin ...17, 85 Life-cycle/Yaşam-siklusu ... 1

Liver biopsy/Karaciğer biyopsi ... 9

Mean platelet volüme/Ortalama trombosit Hacmi ... 38

Mouse/Fare ... 65

Non-invasive marker/Non-invaziv belirteç ... 9

Occult hepatitis B/Okkült hepatit B ...56, 106 Pegylated interferon alpha 2a/Pegile interferon alfa 2a .. 35

Pegylated interferon alpha/Pegile interferon alfa ... 59

Plasmapheresis/Plazmaferez ... 98

PON1/PON1 ... 13

Pregnancy/Gebelik ... 31

Protease inhibitors/Proteaz inhibitörleri ...102

Rat/Rat ... 65

Reactivation/Reaktivasyon ...48, 56 Repeated tests/Tekrarlanan testler... 76

Replication/Replikasyon ... 1

Resistance/Direnç ... 17

Ribavirin/Ribavirin ... 59

RPR/RPR... 28

Seroprevalance/Seroprevalans ... 24, 31, 72, 94 Sickle cell disease/Orak hücreli anemi ... 98

Skin rash/Deri döküntüsü... 59

Socio-economic/Sosyo-ekonomi ... 24

Sofosbuvir/Sofosbuvir ... 62

Superinfection/Süperenfeksiyon... 80

Telaprevir/Telaprevir ...102

Tenofovir/Tenofovir ... 85

Thrombocytopenia/Trombositopeni...102

Treatment/Tedavi ... 89

Tupaia/Tupaia ... 65

Vitamin D/Vitamin D ... 44

2015 Subject Index

Referanslar

Benzer Belgeler

According to the guidelines, response probability to interferon treatment in the third month should be evaluated using HBV DNA level measurements, and

Bu olgumuzu sunmamızdaki amacımız, yaygın oral tutulumlu bir skuamöz hücreli papillom vakasının cerrahi eksizyon ve sistemik interferon alfa kombi- nasyonu ile tedavi ve

When we compared the pre-treatment HRQoL scores of patients with CHC and controls, we determined statistically significantly lower physical functioning (p=0.006), physical

The rate of HBsAg clearance 3 years after treatment was 2% in HBeAg-positive patients and 5% in HBeAg- negative patients treated with Peg-IFN; the rate of HBsAg loss was 4.6%

In the literature, when concurrent cases with HIV infection are excluded, development of acute pancreatitis is reported in 49 cases due to standard IFN alpha and 5 cases due

First of all, definition of occult hepatitis B virus (OHB) infection is long-lasting presence of hepatitis B virus (HBV) deoxyribonucleic acid (DNA) in the liver with

This study aims to evaluate the pre-treatment and post-treatment ophthalmic findings in chronic hepatitis patients who were given PeG-IFn-α treatment and followed up at the

here, we report a patient with chronic hepatitis B who developed spooning (koilonychia) of the left hand middle fingernail and falling off the right big toe nail during PeG-IFn